BK · Healthcare

Bangkok Genomics Innovation Pcl (BKGI)

Diagnostics & Research

Bangkok Genomics Innovation Pcl (BKGI) is listed on BK in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-05-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for BKGI

P/E ratio

18.00

Bangkok Genomics Innovation Pcl (BKGI) — FAQ

What is BKGI's P/E ratio?

The price-to-earnings (P/E) ratio for Bangkok Genomics Innovation Pcl (BKGI) is 18.00 (data as of 2026-05-24).

Does Bangkok Genomics Innovation Pcl pay a dividend?

Dividend yield is not available in the current snapshot for Bangkok Genomics Innovation Pcl (BKGI). Check the MyAverix Finance app for the latest dividend data.

What sector is Bangkok Genomics Innovation Pcl in?

Bangkok Genomics Innovation Pcl (BKGI) is classified in the Healthcare sector (Diagnostics & Research industry).

What exchange is BKGI listed on?

BKGI is listed on BK.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)